Cellular and Molecular Neurobiology

, Volume 26, Issue 7–8, pp 1111–1127 | Cite as

Bone Marrow Stem Cells and Polymer Hydrogels—Two Strategies for Spinal Cord Injury Repair

  • Eva Syková
  • Pavla Jendelová
  • Lucia Urdzíková
  • Petr Lesný
  • Aleš Hejčl
Article

Summary

1. Emerging clinical studies of treating brain and spinal cord injury (SCI) led us to examine the effect of autologous adult stem cell transplantation as well as the use of polymer scaffolds in spinal cord regeneration. We compared an intravenous injection of mesenchymal stem cells (MSCs) or the injection of a freshly prepared mononuclear fraction of bone marrow cells (BMCs) on the treatment of an acute or chronic balloon-induced spinal cord compression lesion in rats. Based on our experimental studies, autologous BMC implantation has been used in a Phase I/II clinical trial in patients (n=20) with a transversal spinal cord lesion.

2. MSCs were isolated from rat bone marrow by their adherence to plastic, labeled with iron-oxide nanoparticles and expanded in vitro. Macroporous hydrogels based on derivatives of 2-hydroxyethyl methacrylate (HEMA) or 2-hydroxypropyl methacrylamide (HPMA) were prepared, then modified by their copolymerization with a hydrolytically degradable crosslinker, N,O-dimethacryloylhydroxylamine, or by different surface electric charges. Hydrogels or hydrogels seeded with MSCs were implanted into rats with hemisected spinal cords.

3. Lesioned animals grafted with MSCs or BMCs had smaller lesions 35 days postgrafting and higher scores in BBB testing than did control animals and also showed a faster recovery of sensitivity in their hind limbs using the plantar test. The functional improvement was more pronounced in MSC-treated rats. In MR images, the lesion populated by grafted cells appeared as a dark hypointense area and was considerably smaller than in control animals. Morphometric measurements showed an increase in the volume of spared white matter in cell-treated animals. In the clinical trial, we compared intraarterial (via a. vertebralis, n=6) versus intravenous administration of BMCs (n=14) in a group of subacute (10–33 days post-SCI, n=8) and chronic patients (2–18 months, n=12). For patient follow-up we used MEP, SEP, MRI, and the ASIA score. Our clinical study revealed that the implantation of BMCs into patients is safe, as there were no complications following cell administration. Partial improvement in the ASIA score and partial recovery of MEP or SEP have been observed in all subacute patients who received cells via a. vertebralis (n=4) and in one out of four subacute patients who received cells intravenously. Improvement was also found in one chronic patient who received cells via a. vertebralis. A much larger population of patients is needed before any conclusions can be drawn. The implantation of hydrogels into hemisected rat spinal cords showed that cellular ingrowth was most pronounced in copolymers of HEMA with a positive surface electric charge. Although most of the cells had the morphological properties of connective tissue elements, we found NF-160-positive axons invading all the implanted hydrogels from both the proximal and distal stumps. The biodegradable hydrogels degraded from the border that was in direct contact with the spinal cord tissue. They were resorbed by macrophages and replaced by newly formed tissue containing connective tissue elements, blood vessels, GFAP-positive astrocytic processes, and NF-160-positive neurofilaments. Additionally, we implanted hydrogels seeded with nanoparticle-labeled MSCs into hemisected rat spinal cords. Hydrogels seeded with MSCs were visible on MR images as hypointense areas, and subsequent Prussian blue histological staining confirmed positively stained cells within the hydrogels.

4. We conclude that treatment with different bone marrow cell populations had a positive effect on behavioral outcome and histopathological assessment after SCI in rats; this positive effect was most pronounced following MSC treatment. Our clinical study suggests a possible positive effect in patients with SCI. Bridging the lesion cavity can be an approach for further improving regeneration. Our preclinical studies showed that macroporous polymer hydrogels based on derivatives of HEMA or HPMA are suitable materials for bridging cavities after SCI; their chemical and physical properties can be modified to a specific use, and 3D implants seeded with different cell types may facilitate the ingrowth of axons.

KEY WORDS:

cell transplantation magnetic resonance spinal cord lesion repair scaffold polymers 

REFERENCES

  1. Akiyama, Y., Radtke, C., Honmou, O., and Kocsis, J. D. (2002b). Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39:229–236.CrossRefPubMedGoogle Scholar
  2. Akiyama, Y., Radtke, C., and Kocsis, J. D. (2002a). Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J. Neurosci. 22:6623–6630.PubMedGoogle Scholar
  3. Azizi, S. A., Stokes, D., Augelli, B. J., DiGirolamo, C., and Prockop, D. J. (1998). Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats–similarities to astrocyte grafts. Proc. Natl. Acad. Sci. U.S.A. 95:3908–3913.CrossRefPubMedGoogle Scholar
  4. Basso, D. M., Beattie, M. S., Bresnahan, J. C., Anderson, D. K., Faden, A. I., Gruner, J. A., et al. (1996). MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma 13:343–359.PubMedGoogle Scholar
  5. Bixby, J. L., and Harris, W. A. (1991). Molecular mechanisms of axon growth and guidance. Annu. Rev. Cell. Biol. 7:117–159.CrossRefPubMedGoogle Scholar
  6. Bjorklund, A., and Lindvall (2000). Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3:537–544.CrossRefPubMedGoogle Scholar
  7. Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Young, W., Baskin, D. S., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322:1405–1411.PubMedCrossRefGoogle Scholar
  8. Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., et al. (1998). Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J. Neurosurg. 89:699–706.PubMedCrossRefGoogle Scholar
  9. Brazelton, T. R., Rossi, F. M., Keshet, G. I., and Blau, H. M. (2000). From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 290:1775–1779.CrossRefPubMedGoogle Scholar
  10. Bregman, B. S. (1987). Spinal cord transplants permit the growth of serotonergic axons across the site of neonatal spinal cord transection. Brain Res. 431:265–279.PubMedGoogle Scholar
  11. Brustle, O., Jones, K. N., Learish, R. D., Karram, K., Choudhary, K., Wiestler, O. D., et al. (1999). Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285:754–756.CrossRefPubMedGoogle Scholar
  12. Chen, X., Katakowski, M., Li, Y., Lu, D., Wang, L., Zhang, L., et al. (2002). Human bone marrow stromal cells cultures conditioned by traumatic brain tissue extracts: Growth factor production. J. Neurosci. Res. 69:687–691.CrossRefPubMedGoogle Scholar
  13. Chong, Z. Z., Kang, J. Q., and Maiese, K. (2002). Hematopoietic factor erythropoietin fosters neuroprotectionthrough novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22:503–514.CrossRefPubMedGoogle Scholar
  14. Chopp, M., and Li, Y. (2002). Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1:92–100.CrossRefPubMedGoogle Scholar
  15. Chopp, M., Zhang, X. H., Li, Y., Wang, L., Chen, J., Lu, D., et al. (2000). Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 11:3001–3005.PubMedGoogle Scholar
  16. Coumans, J. V., Lin, T. T., MacArthur, L., McAtee, M., Nash, C., and Bregman, B. S. (2001). Axonal regeneration and functional recovery after complete spinal cord transection in rats by delazed treatment with transplants and neurotrophins. J. Neurosci. 21:9334–9344.PubMedGoogle Scholar
  17. Dame, C., Wolber, E. M., Freitag, P., Hofmann, D., Bartmann, P., and Fandrey, J. (2003). Trombopoietingene expression in the developing human central nervous system. Brain Res. Dev. Brain Res. 143:217–223.CrossRefPubMedGoogle Scholar
  18. Eaves, C. J., Cashman, J. D., Kay, R. J., Dougherty, G. J., Otsuka, T., Gaboury, L. A., et al. (1991). Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110–117.PubMedGoogle Scholar
  19. Eglitis, M. A., Dawson, D., Park, K. W., and Mouradian, M. M. (1999). Targeting of marrow-derived astrocytes to the ischemic brain. Neuroreport 10:1289–1292.PubMedGoogle Scholar
  20. Fawcett, J. W., and Asher, R. A. (1999). The glial scar and central nervous system repair. Brain Res. Bull. 49:377–391.CrossRefPubMedGoogle Scholar
  21. Geisler, F. H., Coleman, W. P., Grieco, G., and Poonian, D. (2001). The Sygen multicenter acute spinal cord injury study. Spine 26:S87–98.CrossRefPubMedGoogle Scholar
  22. Hejčl, A., Urdzíková, L., Přádný, M., Michálek, J., Jendelová, P., and Syková, E. (2005). Positively charged HEMA-based hydrogels implanted immediately and one week after spinal cord injury in rat. Abstract, Fifth Czech Neuroscience Conference, Prague, Czech Republic.Google Scholar
  23. Hofstetter, C. P., Schwarz, E. J., Hess, D., Widenfalk, J., El Manira, A., Prockop, J. D., and Olson, L. (2002). Marrow stromal cellsform guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. U.S.A. 96:2199–2204.CrossRefGoogle Scholar
  24. Horvat, J. C. (1991). Transplants of fetal neural tissue and autologous peripheral nerves in an attempt to repair spinal cord injuries in the adult rat. An overall view. Paraplegia 29:299–308.PubMedGoogle Scholar
  25. Houle, J. D., and Ziegler, M. K. (1994). Bridging a complete transection lesion of adult rat spinal cord with growth factor-treated nitrocellulose implants. J. Neural Transpl. Plast. 5:115–124.Google Scholar
  26. Houweling, D. A., Lankhorst, A. J., Gispen, W. H., Bar, P. R., and Joosten, E. A. (1998). Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp. Neurol. 153:49–59.CrossRefPubMedGoogle Scholar
  27. Hugenholtz, H., Cass, D. E., Dvorak, M. F., Fewer, D. H., Fox, R. J., Izukawa, D. M., et al. (2002). High-dose methylprednisolone for acute closed spinal cord injury–only a treatment option. Can. J. Neurol. Sci. 29:227–235.Google Scholar
  28. Inoue, M., Honmou, O., Oka, S., Houkin, K., Hashi, K., and Kocsis, J. D. (2003). Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord. Glia 44:111–118.CrossRefPubMedGoogle Scholar
  29. Iwanami, A., Kaneko, S., Nakamura, M., Kanemura, Y., Mori, H., Kobayashi, S., et al. (2005). Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res. 80:182–190.CrossRefPubMedGoogle Scholar
  30. Jendelová, P., Herynek, V., De Croos, J., Glogarová, K., Andersson, B., Hájek, M., and Syková, E. (2003). Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn. Reson. Med. 50:767–776.CrossRefPubMedGoogle Scholar
  31. Jendelová, P., Lesný, P., Přádný, M., Hejčl, A., Michálek, J., and Syková, E. (2004a). Hydrogel implantation into a spinal cord lesion— an alternative to conventional cell grafting. Program No. 106.13.2004. Abstract Viewer/Itinerary Planner: Online.Google Scholar
  32. Jendelová, P., Herynek, V., Urdzíková, L., Glogarová, K., Kroupová, J., Bryja, V., et al. (2004b). MR tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res.:232–243.Google Scholar
  33. Kuhlengel, K. R., Bunge, M. B., Bunge, R. P., and Burton, H. (1990). Implantation of cultured sensory neurons and Schwann cells into lesioned neonatal rat spinal cord. II. Implant characteristics and examination of corticospinal tract growth. J. Comp. Neurol. 293:74–91.CrossRefPubMedGoogle Scholar
  34. Lee, D. H., Strittmatter, S. M., and Sah, D. W. (2003). Targeting the Nogo receptor to treat central nervous system injuries. Nat. Rev. Drug Discov. 2:872–878.CrossRefPubMedGoogle Scholar
  35. Lesný, P., De Croos, J., Přádný, M., Vacik, J., Michálek, J., Woerly, S., and Syková, E. (2002). Polymer hydrogels usable for nervous tissue repair. J. Chem. Neuroanat. 23:243–247.CrossRefPubMedGoogle Scholar
  36. Lesný, P., Přádný, M., Jendelová, P., Michálek, J., Vacik, J., and Syková, E. (in press). Macroporous hydrogels based on 2-hydroxyethyl methacrylate. Part 4: Growth of rat bone marrow stromal cells in three-dimensional hydrogels with positive and negative surface charges and in polyelectrolyte complexes. J. Mater. Sci. Mater. Med. Google Scholar
  37. Liu, S., Bodjarian, N., Langlois, O., Bonnard, A. S., Boisset, N., Peulve, P., et al. (1998). Axonal regrowth through a collagen guidance channel bridging spinal cord to the avulsed C6 roots: Functional recovery in primates with brachial plexus injury. J. Neurosci. Res. 51:723–734.CrossRefPubMedGoogle Scholar
  38. Lu, D., Mahmood, A., Wang, L., Li, Y., Lu, M., and Chopp, M. (2001). Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 12:559–563.CrossRefPubMedGoogle Scholar
  39. Mahmood, A., Lu, D., Wang, L., and Chopp, M. (2002). Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J. Neurotrauma. 19:1609–1617.CrossRefPubMedGoogle Scholar
  40. Majunder, M., Thiede, M., and Mosca, J. (1998). Phenotype and funtional comparison of cultured of marrow derived mesenchymal stem cells and stomal cells. J. Cell. Physiol. 176:57–66.CrossRefGoogle Scholar
  41. Maquet, V., Martin, D., Scholtes, F., Franzen, R., Schoenen, J., Moonen, G., and Jer me, R. (2001). Poly(D,L-lactide) foams modified by poly(ethylene oxide)-block-poly(D,L-lactide) copolymers and a-FGF: in vitro and in vivo evaluation for spinal cord regeneration. Biomaterials 22:1137–1146.CrossRefPubMedGoogle Scholar
  42. Mehler, M. F., Rozental, R., Dougherty, M., Spray, D. C., and Kessler, J. A. (1993). Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362:62–65.CrossRefPubMedGoogle Scholar
  43. Mezey, E., Chandross, K. J., Harta, G., Maki, R. A., and McKercher, S. R. (2000). Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779–1782.CrossRefPubMedGoogle Scholar
  44. Ogawa, Y., Sawamoto, K., Miyta, T., Watanabe, M., Nakamura, M, Bregman, B., et al. (2002). Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 69:925–933.CrossRefPubMedGoogle Scholar
  45. Okada, S., Ishii, K., Yamane, J., Iwanami, A., Ikegami, T., Katoh, H., et al. (2005). In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 19:1839–1841.PubMedGoogle Scholar
  46. Oudega, M., Gautier, S. E., Chapon, P., Fragoso, M., Bates, M. L., Parel, J. M., and Bunge, M. B. (2001). Axonal regeneration into Schwann cell grafts within resorbable poly(alpha-hydroxyacid) guidance channels in the adult rat spinal cord. Biomaterials 22:1125–1136.CrossRefPubMedGoogle Scholar
  47. Park, H. C., Shims, Y. S., Ha, Y., Yoon, S. H., Park, S. R., Choi, B. H., and Park, H. S. (2005). Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 11:913–922.CrossRefPubMedGoogle Scholar
  48. Pitts, L. H., Ross, A., Chase, G. A., and Faden, A. I. (1995). Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J. Neurotrauma 12:235–243.PubMedCrossRefGoogle Scholar
  49. Pointillart, V., Petitjean, M. E., Wiart, L., Vital, J. M., Lassie, P., Thicoipe, M., and Dabadie, P. (2000). Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord. 38:71–76.CrossRefPubMedGoogle Scholar
  50. Přádný, M., Lesný, P., Fiala, J., Vacik, J., Slouf, M., Michálek, J., and Syková, E. (2002). Macroporous hydrogels based on 2-hydroxyethylmethacrylate. Part 1. Copolymers of 2-hydroxyethylmethacrylate with methacrylic acid. Collection Czech Chem. Commun. 68:812–822CrossRefGoogle Scholar
  51. Přádný, M., Michálek, J., Lesný, P., Hejčl, A., Vacík, J., Slouf, M., and Syková, E. (in press). Macroporous hydrogels based on 2-hydroxyethyl methacrylate. Part 5: Hydrolytically degradable materials. J. Mater. Sci. Mater. Med. Google Scholar
  52. Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74.CrossRefPubMedGoogle Scholar
  53. Sasaki, M., Honmou, O., Akiyama, Y., Uede, T., Hashi, K., and Kocsis, J. D. (2001). Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia 35:26–34.CrossRefPubMedGoogle Scholar
  54. Syková, E., and Jendelová, P. (2005). Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann. N. Y. Acad. Sci. 1049:146–160.CrossRefPubMedGoogle Scholar
  55. Syková, E., Jendelová, P., Glogarová, K., Urdzíková, L., Burian, M., and Hájek, M. (2005a). Bone marrow cells as tool for the therapy of spinal cord injury. Program No 819.7 2005. Abstract viewer/Itinerary Planner, Society for Neuroscience, Washington, DC.Google Scholar
  56. Syková, E., Urdzíková, L., Jendelová, P., Burian, M., Glogarová, K., and Hájek, M. (2005b). Bone marrow cells—a tool for spinal cord injury repair. Exp. Neurol. 193:261–262.Google Scholar
  57. Teng, Y. D., Lavik, E. B., Qu, X., Park, K. I., Ourednik, J., Zurakowski, D., et al. (2002). Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. PNAS 99:3024–3029.CrossRefPubMedGoogle Scholar
  58. Urdzíková, L., Jendelová, P., Glogarová, K., Burian, M., Hájek, M., and Syková, E. (in press). Transplantation of bone marrow stem cells as well as mobilization by granulocyte— colony stimulating factor promote recovery after spinal cord injury in rat. J. Neurotrauma Google Scholar
  59. Urdzíková, L., Jendelová, P., Glogarová, K., and Syková, E. (2005). The intravenous treatment with mesenchymal stromal cells promotes functional recovery of chronic spinal cord injuries. In Cassoviensia, F. M. (ed.), 5th International Symposium on Experimental and Clinical Neurobiology. Stara Lesna—The High Tatras, Slovak Republic, Institute of Neurobiology, Slovak Academy of Sciences, Faculty of Medicine, P.J. Šafárik University in Košice, pp. 124.Google Scholar
  60. Venstrom, K. A., and Reichardt, L. F. (1993). Extracellular matrix. 2: Role of extracellular matrix molecules and their receptors in the nervous system. Faseb J. 7:996–1003.PubMedGoogle Scholar
  61. Wang, L., Li, Y., Chen, J., Gautam, S. C., Zhang, Z., Lu, M., and Chopp, M. (2002). Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp. Hematol. 30:831–836.CrossRefPubMedGoogle Scholar
  62. Woerly, S., Doan, V. D., Sosa, N., de Vellis, J., and Espinosa, A. (2001b). Reconstruction of the transected cat spinal cord following NeuroGel implantation: axonal tracing, immunohistochemical and ultrastructural studies. Int. J. Dev. Neurosci. 19:63–83.CrossRefPubMedGoogle Scholar
  63. Woerly, S., Pinet, E., de Robertis, L., Van Diep, D., and Bousmina, M. (2001a). Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). Biomaterials 22:1095–1111.CrossRefPubMedGoogle Scholar
  64. Woerly, S., Pinet, E., De Robertis, L., Bousmina, M., Laroche, G., Roitback, T., et al. (1998). Heterogeneous PHPMA hydrogels for tissue repair and axonal regeneration in the injured spinal cord. J. Biomater. Sci. Polym. Ed. 9:681–711.PubMedGoogle Scholar
  65. Woodbury, D., Schwarz, E. J., Prockop, D. J., and Black, I. B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61:364–370.CrossRefPubMedGoogle Scholar
  66. Wrathall, J. R., Rigamonti, D. D., Braford, M. R., and Kao, C. C. (1982). Reconstruction of the contused cat spinal cord by the delayed nerve graft technique and cultured peripheral non-neuronal cells. Acta Neuropathol. (Berl.) 57:59–69.CrossRefGoogle Scholar
  67. Wu, S., Suzuki, Y., Ejiri, Y., Noda, T., Bai, H., Kitada, M., et al. (2003). Bone marrow stromal cells enhance differentiation of cocultured neurospheres cells and promote regeneration of injured spinal cord. J. Neurosci. Res. 72:343–351.CrossRefPubMedGoogle Scholar
  68. Xu, X. M., Chen, A., Guenard, V., Kleitman, N., and Bunge, M. B. (1997). Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J. Neurocytol. 26:1–16.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Eva Syková
    • 1
    • 2
  • Pavla Jendelová
    • 1
    • 2
  • Lucia Urdzíková
    • 1
    • 2
  • Petr Lesný
    • 1
    • 2
  • Aleš Hejčl
    • 1
    • 2
  1. 1.Institute of Experimental Medicine ASCRVidenskáPrague 4Czech Republic
  2. 2.Center for Cell Therapy and Tissue Repair and Department of Neuroscience, Second Medical Faculty, Charles UniversityPragueCzech Republic

Personalised recommendations